The Journal of Medical Microbiology, Vol 48, Issue 5 425-431, Copyright © 1999 by Society for General Microbiology

JOURNAL ARTICLE

Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity

D. Ben-Nathan, D. A. Padgett and R. M. Loria
Department of Oral Biology, College of Dentistry, Ohio State University, Columbus 43210, USA.

The protective effects of the hormones androstenediol (androstene-3beta, 17beta,-diol; AED) and dehydroepiandrosterone (5-androsten-3beta-ol-17-one; DHEA) on the pathophysiology of two lethal bacterial infections and endotoxin shock were examined. The infections included a gram-positive organism (Enterococcus faecalis) and a gram-negative organism (Pseudomonas aeruginosa). Both hormones protected mice from the lethal bacterial infections and from lipopolysaccharide (LPS) challenge. Treatment of animals lethally infected with P. aeruginosa with DHEA resulted in a 43% protection whereas treatment with AED gave a 67% protection. Both hormones also protected completely animals infected with an LD50 dose of E. faecalis. Similarly, the 88% mortality rate seen in LPS challenge was reduced to 17% and 8.5%, by treatment with DHEA and AED, respectively. The protective influences of both steroids were shown not to be directly antibacterial, but primarily an indirect antitoxin reaction. DHEA appears to mediate its protective effect by a mechanism that blocks the toxin-induced production of pathophysiological levels of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1. AED usually had greater protective effects than DHEA; however, the AED effect was independent of TNF-alpha suppression, both in vivo and in vitro. The data suggest that both DHEA and AED may have a role in the neuro-endocrine regulation of antibacterial immune resistance.

This article has been cited by other articles:

				L. Wang, Y.-D. Wang, W.-J. Wang, Y. Zhu, and D.-J. Li Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor J. Mol. Endocrinol., April 1, 2007; 38(4): 467 - 479. [Abstract] [Full Text] [PDF]

				J. G. Kiang, R. M. Peckham, L. E. Duke, T. Shimizu, I. H. Chaudry, and G. C. Tsokos Androstenediol inhibits the trauma-hemorrhage-induced increase in caspase-3 by downregulating the inducible nitric oxide synthase pathway J Appl Physiol, March 1, 2007; 102(3): 933 - 941. [Abstract] [Full Text] [PDF]

				J. M. FRINCKE, D. R. STICKNEY, N. ONIZUKA-HANDA, A. GARSD, C. READING, S. KRUDSOOD, P. WILAIRATANA, and S. LOOAREESUWAN REDUCTION OF PARASITE LEVELS IN PATIENTS WITH UNCOMPLICATED MALARIA BY TREATMENT WITH HE2000 Am J Trop Med Hyg, February 1, 2007; 76(2): 232 - 236. [Abstract] [Full Text] [PDF]

				L. Szalay, T. Shimizu, T. Suzuki, Y.-C. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G260 - G266. [Abstract] [Full Text] [PDF]

				W. Arlt, F. Hammer, P. Sanning, S. K. Butcher, J. M. Lord, B. Allolio, D. Annane, and P. M. Stewart Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2548 - 2554. [Abstract] [Full Text] [PDF]

				M. R. Sowers, M. Jannausch, J. F. Randolph, D. McConnell, R. Little, B. Lasley, R. Pasternak, K. Sutton-Tyrrell, and K. A. Matthews Androgens Are Associated with Hemostatic and Inflammatory Factors among Women at the Mid-Life J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6064 - 6071. [Abstract] [Full Text] [PDF]

				T. Shimizu, L. Szalay, M. A. Choudhry, M. G. Schwacha, L. W. Rue III, K. I. Bland, and I. H. Chaudry Mechanism of salutary effects of androstenediol on hepatic function after trauma-hemorrhage: role of endothelial and inducible nitric oxide synthase Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G244 - G250. [Abstract] [Full Text] [PDF]

				T. Shimizu, M. A. Choudhry, L. Szalay, L. W. Rue III, K. I. Bland, and I. H. Chaudry Salutary effects of androstenediol on cardiac function and splanchnic perfusion after trauma-hemorrhage Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R386 - R390. [Abstract] [Full Text] [PDF]

				C. J. Malkin, P. J. Pugh, R. D. Jones, D. Kapoor, K. S. Channer, and T. H. Jones The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3313 - 3318. [Abstract] [Full Text] [PDF]

				M. L. Kohut, J. R. Thompson, J. Campbell, G. A. Brown, M. D. Vukovich, D. A. Jackson, and D. S. King Ingestion of a Dietary Supplement Containing Dehydroepiandrosterone (DHEA) and Androstenedione Has Minimal Effect on Immune Function in Middle-Aged Men J. Am. Coll. Nutr., October 1, 2003; 22(5): 363 - 371. [Abstract] [Full Text] [PDF]

				C. Du, M. W. Khalil, and S. Sriram Administration of Dehydroepiandrosterone Suppresses Experimental Allergic Encephalomyelitis in SJL/J Mice J. Immunol., December 15, 2001; 167(12): 7094 - 7101. [Abstract] [Full Text] [PDF]

				C. Du, Q. Guan, M. W. Khalil, and S. Sriram Stimulation of Th2 Response by High Doses of Dehydroepiandrosterone in KLH-Primed Splenocytes Experimental Biology and Medicine, December 1, 2001; 226(11): 1051 - 1060. [Abstract] [Full Text] [PDF]

				P.J. Pugh, K.M. English, T.H. Jones, and K.S. Channer Testosterone: a natural tonic for the failing heart? QJM, October 1, 2000; 93(10): 689 - 694. [Full Text] [PDF]